Molecular Neurobiology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of IJMS focuses on publishing high-quality manuscripts that report on a broad range of topics of general interest to those working in the field of molecular neurobiology. Topics include, but are not limited to, the following:
- Neurobiology
- Neurochemistry
- Neurology
- Neuropathology
- Neurophysiology
- Neuropharmacology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Glioma: Molecular Aspects and Theranostics (Deadline: 29 October 2021)
- Neurobiological Mechanisms Implicated in Stress-Related Psychiatric Disorders (Deadline: 30 October 2021)
- Cerebellar Ataxia (Deadline: 30 October 2021)
- Oligodendrocyte Lineage Cells (Deadline: 31 October 2021)
- Mitochondrial Dynamics in Neurons (Deadline: 31 October 2021)
- Molecular Mechanisms and Pathophysiology of Cerebral Ischemia (Deadline: 31 October 2021)
- Cell Death, Inflammation and Oxidative Stress in Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules (Deadline: 31 October 2021)
- Molecular Mechanisms and Pharmacological Targeting of Neuroprotection (Deadline: 31 October 2021)
- Psychoneuropharmacology (Deadline: 31 October 2021)
- Alzheimer's disease: From Molecular Basis to Therapy (Deadline: 31 October 2021)
- Neuro–Immune Interactions in Health and Disease (Deadline: 31 October 2021)
- Brain Mechanisms of Sleep Related Disorders (Deadline: 31 October 2021)
- Molecular Research on Huntington’s Disease (Deadline: 31 October 2021)
- The Various Molecular Mechanisms Underlying Autism Spectrum Disorders (Deadline: 31 October 2021)
- Role of Neuronal Guidance Cues in Inflammation (Deadline: 31 October 2021)
- Molecular Mechanisms of Synaptic Plasticity (3.0): Genetic and Environmental Factors Involved in Neuronal Changes (Deadline: 31 October 2021)
- The Involvement of Cholinergic and Norepinephrine Network Modulation in Alzheimer’s Disease Cognitive Dysfunction (Deadline: 31 October 2021)
- Epigenetic Regulation in Neurodegeneration Disease (Deadline: 31 October 2021)
- The Synaptic Vesicle Cycle as It Relates to Neurotransmitter Release at Nerve Terminals (Deadline: 31 October 2021)
- Gangliosides: Modes of Action and Cell Fates II (Deadline: 31 October 2021)
- Molecular Mechanisms of Neuronal Death in Neurodegeneration (Deadline: 31 October 2021)
- Molecular Research on Rett Syndrome and Related Disorders (Deadline: 25 November 2021)
- Molecular Pathogenesis of Neurodegeneration: From Fish to Human (Deadline: 30 November 2021)
- Advances in Knowledge in Niemann-Pick Disease Type C: Facts and Perspectives- 2nd Edition (Deadline: 30 November 2021)
- Biomarkers of Treatment Response in Psychiatric Disorders (Deadline: 30 November 2021)
- New Strategies of Neuroprotection and Repair in the Developing Brain (Deadline: 30 November 2021)
- Trace Amine-Associated Receptors in Neuropsychiatric Disorders (Deadline: 30 November 2021)
- Molecular Mechanisms of Alzheimer’s Disease and Brain Tolerance (Deadline: 30 November 2021)
- Inflammation in Neurodegeneration (Deadline: 30 November 2021)
- Role of Tau Protein in Synaptic Deterioration of Alzheimer's Disease (AD) (Deadline: 30 November 2021)
- Neuroinflammation: From Molecular Basis to Therapy (Deadline: 30 November 2021)
- Gene Therapy for Neurodegenerative Disease (Deadline: 30 November 2021)
- Genomics of Brain Disorders 3.0 (Deadline: 30 November 2021)
- Neuroendocrine Factors in Health and Disease (Deadline: 30 November 2021)
- Neurolipids in Neurodegenerative Disorders (Deadline: 30 November 2021)
- Development of Dopaminergic Neurons (Deadline: 30 November 2021)
- Animal Model of the Human Brain: A Mandatory Multi-disciplinary Approach (Deadline: 30 November 2021)
- Molecular Mechanisms and Neural Correlates of General Anesthesia-2nd Edition (Deadline: 1 December 2021)
- Retinal Degeneration and Protection (Deadline: 10 December 2021)
- Orofacial Pain: Molecular Mechanisms, Diagnosis and Treatment 2021 (Deadline: 15 December 2021)
- Epilepsy and Comorbidities in Children: Pathogenesis, Diagnosis and Therapies (Deadline: 17 December 2021)
- Molecular Pathogenesis of Neurodegenerative Diseases Targeting Diagnosis and Treatment (Deadline: 30 December 2021)
- Synaptic Plasticity and Diseases (Deadline: 31 December 2021)
- Therapeutic Implication of Senescent Cell Elimination in Neurodegenerative Diseases (Deadline: 31 December 2021)
- Sodium Voltage-Operated Neural Channel Modulators in Peripheral Nervous System Disorders (Deadline: 31 December 2021)
- Molecular Mechanisms of Addictive Disorders (Deadline: 31 December 2021)
- Dissecting Neurological and Neuropsychiatric Diseases: Neurodegeneration and Neuroprotection (Deadline: 31 December 2021)
- Thalamus and Behavioral Neuroscience (Deadline: 31 December 2021)
- Molecular Mechanisms of Aging-Related Neurodegenerative Diseases (Deadline: 31 December 2021)
- α-Synuclein in Neurons and Glia: From Physiology to Pathology (Deadline: 31 December 2021)
- Modeling Neurological Disorders in Experimental Animals: New Insights and Emerging Roles 2.0 (Deadline: 31 December 2021)
- Glial Cells and Energy Intake: A Field That Is Gaining Weight (Deadline: 31 December 2021)
- The Cellular, Synaptic and Molecular Mechanisms of Action of Central Nervous System Drugs (Deadline: 31 December 2021)
- CNS Injuries (Deadline: 31 December 2021)
- The Molecular Brain and Its Health (Deadline: 31 December 2021)
- Cell Signaling in Neurodegeneration 2.0 (Deadline: 31 December 2021)
- Redox Active Metals in Neurodegenerative Diseases: Therapeutic Implications (Deadline: 31 December 2021)
- Alpha-Synuclein in Neurodegeneration (Deadline: 31 December 2021)
- Neural Signaling, Neuromodulation and Plasticity (Deadline: 31 December 2021)
- Studying Functional and Molecular Connectome of the Human and Animal Brain (Deadline: 31 December 2021)
- Neurobiological Mechanisms of Orofacial Chronic Pain (Deadline: 31 December 2021)
- Glycome and Nervous System (Deadline: 31 December 2021)
- Role of Natural Compounds in Neurological Diseases (Deadline: 31 December 2021)
- Chronic Pain: Spinal and Sovraspinal Neuroinflammation and Associated Negative Affective States-2nd Edition (Deadline: 31 December 2021)
- Axonopathy in Neurodegenerative Diseases (Deadline: 31 December 2021)
- Epigenetic Regulation in Human Brain (Deadline: 31 December 2021)
- Cellular Mechanisms in Neuropathic Pain (Deadline: 31 December 2021)
- Stem Cells in Neurodegenerative Pathologies (Deadline: 31 December 2021)
- The Blood-Brain Barrier in Health and Disease (Deadline: 31 December 2021)
- Molecular Research on Ischemic Stroke (Deadline: 31 December 2021)
- Dementia and Cell Theraputic Strategies (Deadline: 31 December 2021)
- Omics-Based Molecular Mechanisms of Cognition under Stress (Deadline: 31 December 2021)
- Neuronal Voltage-Gated Channel Regulation (Deadline: 10 January 2022)
- Imidazoline Receptors in Diseases of the CNS (Deadline: 25 January 2022)
- Molecular Advances in Schizophrenia (Deadline: 31 January 2022)
- Ribbon Synapses: Molecular Mechanisms of Synaptic Signaling and Involvement in Diseases (Deadline: 31 January 2022)
- Glutamate Receptors in Health and Disease 2021–2022 (Deadline: 31 January 2022)
- Physiological or Pathological Molecular Alterations in Brain Aging (Deadline: 31 January 2022)
- Latest Advances in Neuroscience (Deadline: 31 January 2022)
- Molecular Mechanisms of Brain Repair and Restoration after Stroke (Deadline: 31 January 2022)
- Neuropeptides in Endocrine, Metabolic and Neuroimmune Disorders (Deadline: 31 January 2022)
- Molecular Mechanism in Movement Disorders and Neurotransmitter Diseases (Deadline: 31 January 2022)
- Molecular Mechanisms and Pathophysiology of Acute Stroke (Deadline: 31 January 2022)
- GABAergic and Glycinergic Neurons (Deadline: 31 January 2022)
- Modulation of Autophagic Activity for the Treatment of Alzheimer’s Disease and Dementia (Deadline: 31 January 2022)
- Molecular Research on Amyotrophic Lateral Sclerosis (Deadline: 31 January 2022)
- Molecular Mechanisms of Polyglutamine Diseases (Deadline: 31 January 2022)
- Regulation and Function of Neural Attributes: From Gene to Behavior (Deadline: 31 January 2022)
- New Mechanisms and Therapeutics in Neurological Diseases (Deadline: 31 January 2022)
- The Neurobiology of Substance Addiction (Deadline: 15 February 2022)
- Molecular Mechanisms of Physical Exercise in Neurodegenerative Diseases (Deadline: 28 February 2022)
- Parkinson's Disease and Related Disorders: Mechanisms, Biomarkers, and Models (Deadline: 28 February 2022)
- Neurobiology of Aging and Aging-Related Disorders (Deadline: 28 February 2022)
- Fragile X Syndrome: From Molecular Mechanisms to Therapeutic Approaches (Deadline: 28 February 2022)
- Molecular Circuits Regulating Sleep and Wakeful Consciousness (Deadline: 28 February 2022)
- Modulation of Neuronal Excitability, Synaptic Transmission, and Plasticity in Health and Disease 2.0 (Deadline: 28 February 2022)
- Steering Functional Pathways, Genomic and Non-genomic, to Keep Neurodegeneration in Check (Deadline: 28 February 2022)
- The Mechanisms Regulation of the Neuromuscular Dysfunctions (Deadline: 28 February 2022)
- Molecular Mechanisms of Neural Stem Cells (NSC) Development - Systems Approach (Deadline: 28 February 2022)
- Neuronal Control of Locomotion (Deadline: 28 February 2022)
- Neurobiology of Traumatic Memory: From Molecules to Function (Deadline: 28 February 2022)
- Role of Cellular and Molecular Inflammation in Subarachnoid Hemorrhage 2.0 (Deadline: 28 February 2022)
- Fish Models and Neural Development (Deadline: 28 February 2022)
- Pathogenesis of Alzheimer's Disease (Deadline: 28 February 2022)
- New Advances in Research on Alzheimer's Disease (Deadline: 31 March 2022)
- Cardiovascular Diseases and Aging (Deadline: 31 March 2022)
- Research in Parkinson's Disease (Deadline: 31 March 2022)
- Ischemic Brain Neurodegeneration 2.0 (Deadline: 31 March 2022)
- Natural and Artificial Vesicles and Nanoparticles against Brain Diseases (Deadline: 31 March 2022)
- Molecular Mechanisms of Cerebrovascular Diseases (Deadline: 31 March 2022)
- Single Drug/Multi-Target for the Treatment of Brain Disorders (Deadline: 31 March 2022)
- Effects of Environmental Factors on the Nervous Tissue Functioning: Molecular Bases of Neuropathogenic Mechanisms (Deadline: 31 March 2022)
- Advances in Mechanisms, Diagnosis and Therapy of Multiple Sclerosis and Other Demyelinating Diseases (Deadline: 31 March 2022)
- Effects of Hormones on the Nervous System and Behavior 2.0 (Deadline: 31 March 2022)
- Neuroepigenetic: From Bench to Bedside (Deadline: 31 March 2022)
- CNS Drug Action in Neurodegenerative Diseases 2.0 (Deadline: 31 March 2022)
- Neural Crest Development in Health and Disease (Deadline: 31 March 2022)
- Proteomics in Diagnosis and Treatment of Neurodegenerative Diseases (Deadline: 31 March 2022)
- The Role of Neurons in Human Health and Disease (Deadline: 31 March 2022)
- The Multiple Mechanisms Underlying Neuropathic Pain (II) (Deadline: 31 March 2022)
- Molecular Pharmacology and Genomics in Psychiatry (Deadline: 31 March 2022)
- GABAergic Physiology in Neurological Disorders (Deadline: 31 March 2022)
- Molecular Biomarkers in Neurodevelopmental and Neurodegenerative Disorders (Deadline: 20 April 2022)
- Active Molecules and Complexes for Neurodegenerative Prevention (Deadline: 30 April 2022)
- Molecular Mechanisms Employed by Neurons to Receive and Transduce Signals Essential for Learning and Memory (Deadline: 30 April 2022)
- Plasticity and Neurodegenerative Diseases (Deadline: 30 April 2022)
- Role of Dopamine in Health and Disease—Biological Aspect (Deadline: 30 April 2022)
- Glial-Neuronal Interactions in Neurological Disorders: Molecular Mechanisms and Potential Points for Intervention 2.0 (Deadline: 30 April 2022)
- Pathophysiology and Molecular Mechanisms in Chronic Brain Injury (Deadline: 30 April 2022)
- The Role of Cerebrospinal Fluid and Blood Biomarkers in Neurological Diseases (Deadline: 30 April 2022)
- Molecular Mechanism Underlying Rare Inherited Neurological Diseases (Deadline: 30 April 2022)
- Pathogenesis and Treatment of Autism Spectrum Disorders 2.0 (Deadline: 15 May 2022)
- Connecting In Vitro, In Vivo, and Ex Vivo Studies in Neurodegenerative Diseases (Deadline: 31 May 2022)
- Development of New Drugs against Stroke (Deadline: 31 May 2022)
- Identifying the Molecular Mechanisms of Psychiatric Disorders to Define New Therapeutic Targets (Deadline: 31 May 2022)
- Neurogenesis and Neural Plasticity 2.0 (Deadline: 31 May 2022)
- Synaptic Vulnerability: From Biological to Therapeutic Point of View (Deadline: 30 June 2022)
- Advances in Stress and Depression Research: Neurobiology, Models, Biomarkers and Therapies (Deadline: 30 June 2022)
- Neuroinflammation in Parkinson's Disease (Deadline: 30 June 2022)
- Molecular Research on Neural Stem Cells in Physiological and Pathological Condition (Deadline: 31 August 2022)
- Neurobiology of Parkinson’s Disease (Deadline: 31 December 2022)
Topical Collections
Following topical collections within this section are currently open for submissions:
